Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.64 |
| ▸ | TERT | O14746 | 3/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.63 |
| ▸ | PPARG | P37231 | 3/20 | 0.63 |
| ▸ | PPARD | Q03181 | 3/20 | 0.63 |
| ▸ | PPARA | Q07869 | 3/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.63 |
| ▸ | BLM | P54132 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | FABP4 | P15090 | 2/20 | 0.63 |
| ▸ | FAAH | O00519 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | GMNN | O75496 | 1/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL540326 | 1.00 | EPHX2 (0.64) | EPHX2TERTPTPN1PPARGPPARD | |
| Bromide SCHEMBL17743564 | 0.98 | EPHX2 (0.62) | EPHX2TERTPTPN1PPARGPPARD | |
| Hydrochloric Acid SCHEMBL565816 | 0.98 | EPHX2 (0.62) | EPHX2TERTPTPN1PPARGPPARD | |
| Fluoride SCHEMBL17743568 | 0.98 | EPHX2 (0.62) | EPHX2TERTPTPN1PPARGPPARD | |
| Iodide SCHEMBL21048369 | 0.98 | EPHX2 (0.62) | EPHX2TERTPTPN1PPARGPPARD | |
| Iodide SCHEMBL17743505 | 0.98 | EPHX2 (0.62) | EPHX2TERTPTPN1PPARGPPARD | |
| Stearic Acid SCHEMBL6898220 | 0.93 | PPARG (0.77) | EPHX2TERTPTPN1PPARGPPARD | |
| Sulfuric Acid SCHEMBL17743519 | 0.93 | EPHX2 (0.57) | EPHX2TERTPTPN1PPARGPPARD | |
| SCHEMBL10793545 | 0.91 | EPHX2 (0.59) | EPHX2TERTPTPN1PPARGPPARD | |
| SCHEMBL10793538 | 0.91 | EPHX2 (0.59) | EPHX2TERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2098567-B1 | ACRYLIC RUBBER COMPOSITION AND VULCANIZATE THEREOF | DENKI KAGAKU KOGYO KK (JP) | 2011-11-16 | — | — | EP | claimed |
| US-8012556-B2 | Acrylic rubber composition and its vulcanized product | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2011-09-06 | — | — | US | claimed |
| US-20100009105-A1 | ACRYLIC RUBBER COMPOSITION AND VULCANIZED PRODUCT | DENKI KAGAKU KIGYO KABUSHIKI KAISHA (JP) | 2010-01-14 | — | — | US | claimed |
| EP-2098567-A1 | ACRYLIC RUBBER COMPOSITION AND VULCANIZATE THEREOF | Denki Kagaku Kogyo Kabushiki Kaisha (JP) | 2009-09-09 | — | — | EP | claimed |
| EP-4640769-A1 | CONDUCTIVE POLYMER-CONTAINING DISPERSION, SOLID ELECTROLYTE CAPACITOR, AND PRODUCTION METHOD FOR SAME | Resonac Corporation (JP) | 2025-10-29 | — | — | EP | disclosed |
| US-12278061-B1 | Conductive polymer-containing dispersion liquid, solid electrolytic capacitor and method for producing same | RESONAC CORPORATION (JP) | 2025-04-15 | — | — | US | disclosed |
| US-20250118500-A1 | CONDUCTIVE POLYMER-CONTAINING DISPERSION LIQUID, SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR PRODUCING SAME | RESONAC CORPORATION (JP) | 2025-04-10 | — | — | US | disclosed |
| US-20250069818-A1 | METHOD FOR PRODUCING POLYMER DISPERSION FOR SOLID ELECTROLYTIC CAPACITOR, AND METHOD FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR | RESONAC CORPORATION (JP) | 2025-02-27 | — | — | US | disclosed |
| WO-2024236965-A1 | ELECTROCONDUCTIVE ADHESIVE COMPOSITION | 京都エレックス株式会社 | 2024-11-21 | — | — | WO | disclosed |
| WO-2024236964-A1 | CONDUCTIVE PASTE COMPOSITION | 京都エレックス株式会社 | 2024-11-21 | — | — | WO | disclosed |
| EP-4456099-A1 | METHOD FOR PRODUCING POLYMER DISPERSION FOR SOLID ELECTROLYTIC CAPACITOR, AND METHOD FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR | Resonac Corporation (JP) | 2024-10-30 | — | — | EP | disclosed |
| CN-118742614-A | Dispersion containing conductive polymer, solid electrolytic capacitor, and method for producing same | 株式会社力森诺科 | 2024-10-01 | — | — | CN | disclosed |
| EP-1473323-A1 | Polyethylene composition and process for producing same | Tosoh Corporation (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-20040214953-A1 | Polyethylene composition and process for producing same | TOSOH CORPORATION | 2004-10-28 | — | — | US | disclosed |
| US-20030129221-A1 | High efficiency encapsulation of charged therapeutic agents in lipid vesicles | SEMPLE SEAN C (CA) | 2003-07-10 | — | — | US | disclosed |
| US-6287591-B1 | STABLE FOR THERAPUTIC USE, HIV, CYTOMEGALO VIRUS, ANTIINFLAMMATORY, ANTITUMOR | INEX PHARMACEUTICALS CORP. (CA) | 2001-09-11 | — | — | US | disclosed |
| EP-1027033-A2 | HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES | Inex Pharmaceuticals Corp. (CA) | 2000-08-16 | — | — | EP | disclosed |
| WO-1998051278-A2 | HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES | INEX PHARMACEUTICALS CORPORATION (CA) | 1998-11-19 | — | — | WO | disclosed |
| US-4699627-A | SECONDARY, TERTIARY AND QUATERNARY DYE-RETAINING COMPOUNDS ON FIBER SURFACE; COLORFAST | AKZONA INCORPORATED (US) | 1987-10-13 | — | — | US | disclosed |
| US-4048118-A | ALKALI METAL SALT OF ORGANIC ACID, AMINE SALT OF PHYTIC ACID | SHOWA DENKO K.K. (JA) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030129221-A1 | High efficiency encapsulation of charged therapeutic agents in lipid vesicles | PHOSPHO1, LIPA, CHMP4B | EPHX2 2963/4885TERT 3493/4885PTPN1 3941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.